Advanced Therapeutic Medicinal Products (ATMPs) Enabled by Regenerative Medicine and Gene Editing Technologies

Third-cycle level | 2.0 credits (HEC) | Course code: H5F6037
HT 2025
Study period: 2025-10-06 - 2025-10-14
LANGUAGE OF INSTRUCTION: The course is given in English
Application period: 2025-04-15 - 2025-05-06
+

Course description

Are you ready to explore the future of medicine? This cutting-edge course delves into the rapidly evolving field of Advanced Therapeutic Medicinal Products (ATMPs), where regenerative medicine and gene editing technologies are transforming healthcare.

Through expert-led lectures, hands-on sessions, and real-world case studies, you will gain in-depth knowledge of ATMP development, regulatory landscapes, and clinical applications. Whether you’re a researcher, clinician,  this course will equip you with the skills and insights needed to be at the forefront of next-generation therapies.

Join us and become part of the revolution in personalized and regenerative medicine!

Prerequisites and Selection

Prerequisite courses, or equivalent

No prerequisite courses, or equivalent, demanded for this course.

Selection

Selection will be based on:  
1) the relevance of the course syllabus for the applicant’s individual study plan/research (according to written motivation). 
2) start date of doctoral studies (priority given to earlier start date). 

 

Course director

Course Director: Jose Inzunza
Co-organizers: Jonathan Arias and Ivan Nalvarte

Course syllabus

H5F6037

Department

Department of Laboratory Medicine

Doctoral programme

Development and Regeneration (DevReg)

Type of course

**Other course

Keywords

gene editing, regenerative medicine, AMTP

CONTACTJose Inzunza

jose.inzunza@ki.se